Sputum cell counts and methacholine hyperresponsiveness as asthma outcomes - 29/08/12
Disclosure of potential conflict of interest: P. Nair has received consultancy fees from Roche and GlaxoSmithKline, has received research support from GlaxoSmithKline and Pulmatrix, is listed on an international patent for a sputum filtration device, and has received travel expenses from Novartis. D. Cockcroft has received research support from Amgen AllerGen and has received royalties from AllerGen. |
|
Editor’s note: There is no accompanying reply to this correspondence. |
Vol 130 - N° 3
P. 823 - septembre 2012 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?